Hazım Alper Gürsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hazım Alper Gürsu has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Ibrahim İlker Cetin
Department of Pediatric Cardiology, Ankara Yıldırım Beyazıt University, Ankara, Türkiye
13 shared publications - Utku Pamuk
Ankara Yıldırım Beyazıt University
10 shared publications - Emine Azak
Department of Pediatric Cardiology, University of Health Sciences, Ankara 06800, Türkiye
8 shared publications - Ahmet Vedat Kavurt
Department of Pediatric Cardiology, Ministry of Health, Ankara City Hospital, Ankara, Turkey
6 shared publications - Yasemin Özdemir Şahan
Department of Pediatric Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye
6 shared publications - Ayşe Esin Kibar Gül
Department of Pediatric Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
5 shared publications
Latest Publications
- 1 August 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1745-1747
Incidentally diagnosed severe pulmonary valvar stenosis complicated by secondary cardiac hepatopathy in an adolescent: balloon valvoplasty as a bridge to surgery
Severe pulmonary valvar stenosis may remain silent into adolescence. A 17-year-old girl attended with vaginal bleeding; the diagnosis rested on a grade 6/6 murmur found on examination. Aminotransferases rose despite correction of anaemia and hypotension and fell only after balloon valvoplasty relieved the obstruction. The valve being dysplastic, valvoplasty was not curative, but it reversed the hepatic injury and allowed valve replacement to proceed safely.
- 1 August 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1745-1747
Incidentally diagnosed severe pulmonary valvar stenosis complicated by secondary cardiac hepatopathy in an adolescent: balloon valvoplasty as a bridge to surgery
Severe pulmonary valvar stenosis may remain silent into adolescence. A 17-year-old girl attended with vaginal bleeding; the diagnosis rested on a grade 6/6 murmur found on examination. Aminotransferases rose despite correction of anaemia and hypotension and fell only after balloon valvoplasty relieved the obstruction. The valve being dysplastic, valvoplasty was not curative, but it reversed the hepatic injury and allowed valve replacement to proceed safely.
- Open Access
- 14 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5499
Transcatheter Management of Congenital and Acquired Venous Lesions in Children
Background: Congenital and acquired venous abnormalities in children represent a heterogeneous group of conditions associated with significant clinical morbidity, including systemic desaturation, hepatic dysfunction, and life-threatening hemodynamic compromise. Evidence regarding transcatheter management across this diverse spectrum remains limited and largely confined to small, lesion-specific series. This study aimed to evaluate the feasibility, procedural, and clinical outcomes of transcatheter venous interventions in a heterogeneous pediatric population. Methods: This retrospective single-center study included all consecutive pediatric patients (median age: 9 years; range: 2 days–17 years) who underwent a total of 28 transcatheter procedures for congenital and acquired venous abnormalities between January 2022 and September 2025. Lesions included congenital portosystemic shunts (n = 4), systemic venous stenoses (n = 2), obstructed pulmonary venous pathways (n = 3), and veno-venous collaterals or azygos/hemiazygos continuation associated with Glenn circulation (n = 9). Procedural strategies were tailored according to anatomical characteristics, and outcomes were assessed in terms of technical success, procedural complications, and lesion-specific clinical and hemodynamic improvement. Results: A total of 28 transcatheter procedures were performed in 18 patients. The median procedure duration was 120 min (range, 35–235 min), and the median follow-up duration was 13.5 months (range, 0.6–35 months). During follow-up, two patients required reintervention for restenosis of previously treated lesions, whereas five additional procedures were performed because of newly developed veno-venous collaterals. Transcatheter interventions resulted in lesion-specific clinical and hemodynamic improvements, including reductions in serum ammonia levels, relief of venous obstruction, and improvements in oxygen saturation. One patient with complex pulmonary venous obstruction died following subsequent surgery despite initial hemodynamic improvement. Conclusions: In this single-center experience, transcatheter venous interventions were feasible and were associated with favorable immediate and mid-term clinical and hemodynamic outcomes in children with diverse venous abnormalities. Given the small sample size, heterogeneous patient population, and retrospective design, these findings should be considered preliminary. Larger prospective multicenter studies are warranted to better define optimal patient selection, timing of intervention, and long-term outcomes.
- 14 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5499
Open AccessTranscatheter Management of Congenital and Acquired Venous Lesions in Children
Background: Congenital and acquired venous abnormalities in children represent a heterogeneous group of conditions associated with significant clinical morbidity, including systemic desaturation, hepatic dysfunction, and life-threatening hemodynamic compromise. Evidence regarding transcatheter management across this diverse spectrum remains limited and largely confined to small, lesion-specific series. This study aimed to evaluate the feasibility, procedural, and clinical outcomes of transcatheter venous interventions in a heterogeneous pediatric population. Methods: This retrospective single-center study included all consecutive pediatric patients (median age: 9 years; range: 2 days–17 years) who underwent a total of 28 transcatheter procedures for congenital and acquired venous abnormalities between January 2022 and September 2025. Lesions included congenital portosystemic shunts (n = 4), systemic venous stenoses (n = 2), obstructed pulmonary venous pathways (n = 3), and veno-venous collaterals or azygos/hemiazygos continuation associated with Glenn circulation (n = 9). Procedural strategies were tailored according to anatomical characteristics, and outcomes were assessed in terms of technical success, procedural complications, and lesion-specific clinical and hemodynamic improvement. Results: A total of 28 transcatheter procedures were performed in 18 patients. The median procedure duration was 120 min (range, 35–235 min), and the median follow-up duration was 13.5 months (range, 0.6–35 months). During follow-up, two patients required reintervention for restenosis of previously treated lesions, whereas five additional procedures were performed because of newly developed veno-venous collaterals. Transcatheter interventions resulted in lesion-specific clinical and hemodynamic improvements, including reductions in serum ammonia levels, relief of venous obstruction, and improvements in oxygen saturation. One patient with complex pulmonary venous obstruction died following subsequent surgery despite initial hemodynamic improvement. Conclusions: In this single-center experience, transcatheter venous interventions were feasible and were associated with favorable immediate and mid-term clinical and hemodynamic outcomes in children with diverse venous abnormalities. Given the small sample size, heterogeneous patient population, and retrospective design, these findings should be considered preliminary. Larger prospective multicenter studies are warranted to better define optimal patient selection, timing of intervention, and long-term outcomes.
- Open Access
- 23 March 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-5
Transcatheter atrial septal defect closure in children weighing ≤15 kg: A single-center experience
Objective: The aim of this study was to assess the feasibility, safety, and outcomes of transcatheter atrial septal defect (ASD) closure in children weighing ≤15 kg, a group in whom transcatheter intervention is often deferred due to limited evidence and perceived procedural risks. Materials and Methods: This retrospective single-center study included 34 children weighing ≤15 kg who underwent transcatheter ASD closure. Demographic, echocardiographic, procedural, and post-procedural follow-up data were analyzed. Results: The mean age was 4.14±1.16 years, and the mean ASD diameter on transthoracic echocardiography was 10.41± 2.96 mm. The median balloon-sized ASD diameter was 14.30 mm (IQR: 12–17). All procedures were performed using Amplatzer Septal Occluder devices, with a 100% procedural success rate. The mean pulmonary artery pressure was 19.50±5.01 mmHg, and median pulmonary vascular resistance was 0.97 Wood units (0.44-1.20). A transient episode of supraventricular tachycardia occurred in one patient (2.94%), with no device embolization or other major complications observed. In most patients, right ventricular dimensions normalized and no residual shunt was observed by the first postoperative day. Conclusion: Transcatheter ASD closure in carefully selected children weighing ≤15 kg appears to be a safe and effective procedure, achieving high procedural success and low complication rates comparable to those observed in heavier patients. Early right ventricular remodeling and the absence of major adverse events further support the feasibility of this approach in appropriately selected cases.
- 23 March 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-5
Open AccessTranscatheter atrial septal defect closure in children weighing ≤15 kg: A single-center experience
Objective: The aim of this study was to assess the feasibility, safety, and outcomes of transcatheter atrial septal defect (ASD) closure in children weighing ≤15 kg, a group in whom transcatheter intervention is often deferred due to limited evidence and perceived procedural risks. Materials and Methods: This retrospective single-center study included 34 children weighing ≤15 kg who underwent transcatheter ASD closure. Demographic, echocardiographic, procedural, and post-procedural follow-up data were analyzed. Results: The mean age was 4.14±1.16 years, and the mean ASD diameter on transthoracic echocardiography was 10.41± 2.96 mm. The median balloon-sized ASD diameter was 14.30 mm (IQR: 12–17). All procedures were performed using Amplatzer Septal Occluder devices, with a 100% procedural success rate. The mean pulmonary artery pressure was 19.50±5.01 mmHg, and median pulmonary vascular resistance was 0.97 Wood units (0.44-1.20). A transient episode of supraventricular tachycardia occurred in one patient (2.94%), with no device embolization or other major complications observed. In most patients, right ventricular dimensions normalized and no residual shunt was observed by the first postoperative day. Conclusion: Transcatheter ASD closure in carefully selected children weighing ≤15 kg appears to be a safe and effective procedure, achieving high procedural success and low complication rates comparable to those observed in heavier patients. Early right ventricular remodeling and the absence of major adverse events further support the feasibility of this approach in appropriately selected cases.
- 11 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2623-2626
Succesfull transcatheter occlusion of a patent ductus venosus in a newborn with lifetech® cera vascular plug
Persistent ductus venosus is an extremely rare disease that causes liver failure, hypoxaemia, and encephalopathy. We report the successful treatment of our patient with elevated transaminase and ammonia levels due to patent ductus venosus, diagnosed in the neonatal period and treated with a vascular plug device.
- 11 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2623-2626
Succesfull transcatheter occlusion of a patent ductus venosus in a newborn with lifetech® cera vascular plug
Persistent ductus venosus is an extremely rare disease that causes liver failure, hypoxaemia, and encephalopathy. We report the successful treatment of our patient with elevated transaminase and ammonia levels due to patent ductus venosus, diagnosed in the neonatal period and treated with a vascular plug device.
- 16 September 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2218-2224
Transcatheter Ventricular Septal Defect Closure in Children < 10 kg: Anatomical Challenges, and Outcomes with the Konar MFO Device
This study evaluated the feasibility, safety, and mid-term outcomes of transcatheter ventricular septal defect (VSD) closure using the Konar MFO device in infants weighing < 10 kg, focusing on procedural challenges and anatomical complexities. A retrospective single-center analysis included 34 consecutive patients (mean age: 14.8 months; mean weight: 7.4 kg) who underwent transcatheter VSD closure between January 2022 and December 2024 via transfemoral or transjugular approaches. Technical success was achieved in 94.1% (32/34) of cases. Major complications were rare (5.9%), with no device embolization, arrhythmias, or new-onset valvular regurgitation. The Konar MFO device was successfully deployed across diverse VSD morphologies, including perimembranous, muscular outlet, mid-muscular, and apical-muscular defects, as well as cases with aortic override or multifocal defects requiring dual-device implantation. Procedural challenges, such as papillary muscle knotting during wire manipulation, were managed with tailored strategies, enabling safe device placement in all patients. Individualized procedural modifications, including novel dual-device and access strategies, enabled safe closure even in anatomically complex cases. At a median follow-up of 17 months, all patients demonstrated sustained defect closure, hemodynamic improvement, and resolution of symptoms. In conclusion, transcatheter VSD closure with the Konar MFO device provides high procedural success and favorable mid-term outcomes in infants < 10 kg, including those with challenging anatomies. Unlike previous reports focusing mainly on procedural success, this study systematically addresses anatomical complexities and mid-term outcomes in infants < 10 kg. Larger multicenter studies with extended follow-up are needed to confirm long-term safety and standardize procedural strategies.
- 16 September 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2218-2224
Transcatheter Ventricular Septal Defect Closure in Children < 10 kg: Anatomical Challenges, and Outcomes with the Konar MFO Device
This study evaluated the feasibility, safety, and mid-term outcomes of transcatheter ventricular septal defect (VSD) closure using the Konar MFO device in infants weighing < 10 kg, focusing on procedural challenges and anatomical complexities. A retrospective single-center analysis included 34 consecutive patients (mean age: 14.8 months; mean weight: 7.4 kg) who underwent transcatheter VSD closure between January 2022 and December 2024 via transfemoral or transjugular approaches. Technical success was achieved in 94.1% (32/34) of cases. Major complications were rare (5.9%), with no device embolization, arrhythmias, or new-onset valvular regurgitation. The Konar MFO device was successfully deployed across diverse VSD morphologies, including perimembranous, muscular outlet, mid-muscular, and apical-muscular defects, as well as cases with aortic override or multifocal defects requiring dual-device implantation. Procedural challenges, such as papillary muscle knotting during wire manipulation, were managed with tailored strategies, enabling safe device placement in all patients. Individualized procedural modifications, including novel dual-device and access strategies, enabled safe closure even in anatomically complex cases. At a median follow-up of 17 months, all patients demonstrated sustained defect closure, hemodynamic improvement, and resolution of symptoms. In conclusion, transcatheter VSD closure with the Konar MFO device provides high procedural success and favorable mid-term outcomes in infants < 10 kg, including those with challenging anatomies. Unlike previous reports focusing mainly on procedural success, this study systematically addresses anatomical complexities and mid-term outcomes in infants < 10 kg. Larger multicenter studies with extended follow-up are needed to confirm long-term safety and standardize procedural strategies.
- 25 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (6) , 2468-2473
Cell-to-Lumen Wire Switch Technique for Stent Re-Access in Congenital Heart Disease: A Novel Method for Challenging Re-Interventions
Re-accessing previously implanted stents in children with complex congenital heart disease presents significant technical challenges, particularly when severe angulation or tortuosity makes true lumen entry nearly impossible and the guidewire instead passes through a stent strut. In this retrospective case series, we describe the Cell-to-Lumen Wire Switch Technique as a novel and effective solution to this problem. The study included 14 pediatric patients (median age: 12 months) who had previously undergone stent implantation in either the right ventricular outflow tract (RVOT) or a vertically oriented ductus arteriosus. The technique involved advancing an initial guidewire through a stent cell to guide catheter positioning, followed by the insertion of a second wire through the true stent lumen to achieve coaxial alignment. In four cases with severe angulation or vertical ductal orientation, a modified approach was used, employing support wires placed either from the right ventricle across the aortic valve or from the carotid artery into the descending aorta to facilitate catheter positioning. All patients successfully underwent re-access using this technique without acute or delayed complications. Balloon dilatation was performed in eight patients, re-stenting in three, while three required no further intervention. The Cell-to-Lumen Wire Switch Technique proved to be a safe, reproducible, and hardware-sparing method that may offer particular advantages in small children where anatomical constraints make conventional dual-wire or buddy wire strategies impractical. This technique expands the interventional toolkit for complex re-access scenarios in pediatric patients.
- 25 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (6) , 2468-2473
Cell-to-Lumen Wire Switch Technique for Stent Re-Access in Congenital Heart Disease: A Novel Method for Challenging Re-Interventions
Re-accessing previously implanted stents in children with complex congenital heart disease presents significant technical challenges, particularly when severe angulation or tortuosity makes true lumen entry nearly impossible and the guidewire instead passes through a stent strut. In this retrospective case series, we describe the Cell-to-Lumen Wire Switch Technique as a novel and effective solution to this problem. The study included 14 pediatric patients (median age: 12 months) who had previously undergone stent implantation in either the right ventricular outflow tract (RVOT) or a vertically oriented ductus arteriosus. The technique involved advancing an initial guidewire through a stent cell to guide catheter positioning, followed by the insertion of a second wire through the true stent lumen to achieve coaxial alignment. In four cases with severe angulation or vertical ductal orientation, a modified approach was used, employing support wires placed either from the right ventricle across the aortic valve or from the carotid artery into the descending aorta to facilitate catheter positioning. All patients successfully underwent re-access using this technique without acute or delayed complications. Balloon dilatation was performed in eight patients, re-stenting in three, while three required no further intervention. The Cell-to-Lumen Wire Switch Technique proved to be a safe, reproducible, and hardware-sparing method that may offer particular advantages in small children where anatomical constraints make conventional dual-wire or buddy wire strategies impractical. This technique expands the interventional toolkit for complex re-access scenarios in pediatric patients.
- Open Access
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 519-529
Analysis of perioperative factors in the development of early Fontan failure : a single-center experience
Aim Early Fontan failure (EFF) after Fontan surgery is rarely observed. Examining perioperative factors associated with this complication, which can lead to mortality and morbidity , is crucial for early diagnosis and treatment. Material and Methods All pediatric patients who underwent Fontan surgery between 2019 and 2023 were retrospectively analyzed. Preoperative demographic, echocardiographic, and angiographic data were collected. Hospital data related to operative and postoperative variables were retrospectively examined. The relationship between these variables and the development of EFF was investigated. Results A total of 21 Fontan patients were included in this study, and 10 of them (47.6%) developed EFF. Postoperatively, three patients (14.2%) died. Of the patients, 52.4% were male, with a median age of 4.5 years. Among the findings, postoperative maximum vasoactive-inotropic score (maxVIS) within the first 24 postoperative hour (p=0.023) and initial blood gas lactate values (p=0,019) were significantly higher in patient who developed EFF. Furthermore, the need for renal replacement therapy (p=0.020) and extracorporeal membrane oxygenation (ECMO) (p=0.020) were found to be associated with EFF. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF. Conclusion The postoperative maxVIS value in postoperative 24 hour and initial lactate levels in intensive care unit were found to be associated with EFF development. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF.
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 519-529
Open AccessAnalysis of perioperative factors in the development of early Fontan failure : a single-center experience
Aim Early Fontan failure (EFF) after Fontan surgery is rarely observed. Examining perioperative factors associated with this complication, which can lead to mortality and morbidity , is crucial for early diagnosis and treatment. Material and Methods All pediatric patients who underwent Fontan surgery between 2019 and 2023 were retrospectively analyzed. Preoperative demographic, echocardiographic, and angiographic data were collected. Hospital data related to operative and postoperative variables were retrospectively examined. The relationship between these variables and the development of EFF was investigated. Results A total of 21 Fontan patients were included in this study, and 10 of them (47.6%) developed EFF. Postoperatively, three patients (14.2%) died. Of the patients, 52.4% were male, with a median age of 4.5 years. Among the findings, postoperative maximum vasoactive-inotropic score (maxVIS) within the first 24 postoperative hour (p=0.023) and initial blood gas lactate values (p=0,019) were significantly higher in patient who developed EFF. Furthermore, the need for renal replacement therapy (p=0.020) and extracorporeal membrane oxygenation (ECMO) (p=0.020) were found to be associated with EFF. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF. Conclusion The postoperative maxVIS value in postoperative 24 hour and initial lactate levels in intensive care unit were found to be associated with EFF development. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF.
- 12 May 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (6) , 1-8
Cardiac involvement of Behcet’s disease in children: a single-center study from Turkey
Cardiac involvement such as intracardiac thrombosis, valve insufficiency, and myocardial infarction may, though rarely, develop in Behçet’s disease. The purpose of this study was to evaluate the characteristics and predictors of cardiac involvement in Behçet’s disease in children. It also aimed to investigate the effect of sex on Behçet’s disease and cardiac involvement. This retrospective descriptive analytical study was conducted in patients under 18 years of age who were diagnosed with Behcet’s disease. Clinical, laboratory, electrocardiographic and echocardiographic findings of the patients were obtained from electronic medical records. Ninety patients with Behçet’s disease were included in the study. Of the patients, 50 (53.8%) were female and the median age at the diagnosis time was 15 (2–18) years. Cardiac involvement was observed in 14 of 90 Behçet’s disease patients and valvulitis was the most common involvement. Intracardiac thrombus was detected in 4 (4.3%) patients: two in the right ventricle, one in the right atrium, and one in the left atrium. The probability of intracardiac thrombus was higher in younger patients and in those who had increased levels of erythrocyte sedimentation rate (ESR) and platelets (PLT) at the time of diagnosis. The risk of intracardiac thrombus development was 13 times higher in patients with erythema nodosum (95% CI = 1.32–127,7). Conclusions: The most common cardiac manifestations of Behçet’s disease in children are valvulitis and intracardiac thrombus. Younger age, increased ESR and PLT, and the presence of erythema nodosum may alert the clinician to the possibility of intracardiac thrombus. Sex has not been shown to have an effect on cardiac involvement. What is Known: • Cardiac involvements such as valvulitis and intracardiac thrombus may be observed in childhood Behçet's disease patients. • The risk of developing intracardiac thrombus is highest in young men, and this is more common in the right heart. What is New: • Intracardiac thrombus was more likely to occur in the presence of erythema nodosum and those with high erythrocyte sedimentation rate and platelet count at the time of diagnosis. • Sex has not been shown to have an effect on cardiac involvement.
- 12 May 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (6) , 1-8
Cardiac involvement of Behcet’s disease in children: a single-center study from Turkey
Cardiac involvement such as intracardiac thrombosis, valve insufficiency, and myocardial infarction may, though rarely, develop in Behçet’s disease. The purpose of this study was to evaluate the characteristics and predictors of cardiac involvement in Behçet’s disease in children. It also aimed to investigate the effect of sex on Behçet’s disease and cardiac involvement. This retrospective descriptive analytical study was conducted in patients under 18 years of age who were diagnosed with Behcet’s disease. Clinical, laboratory, electrocardiographic and echocardiographic findings of the patients were obtained from electronic medical records. Ninety patients with Behçet’s disease were included in the study. Of the patients, 50 (53.8%) were female and the median age at the diagnosis time was 15 (2–18) years. Cardiac involvement was observed in 14 of 90 Behçet’s disease patients and valvulitis was the most common involvement. Intracardiac thrombus was detected in 4 (4.3%) patients: two in the right ventricle, one in the right atrium, and one in the left atrium. The probability of intracardiac thrombus was higher in younger patients and in those who had increased levels of erythrocyte sedimentation rate (ESR) and platelets (PLT) at the time of diagnosis. The risk of intracardiac thrombus development was 13 times higher in patients with erythema nodosum (95% CI = 1.32–127,7). Conclusions: The most common cardiac manifestations of Behçet’s disease in children are valvulitis and intracardiac thrombus. Younger age, increased ESR and PLT, and the presence of erythema nodosum may alert the clinician to the possibility of intracardiac thrombus. Sex has not been shown to have an effect on cardiac involvement. What is Known: • Cardiac involvements such as valvulitis and intracardiac thrombus may be observed in childhood Behçet's disease patients. • The risk of developing intracardiac thrombus is highest in young men, and this is more common in the right heart. What is New: • Intracardiac thrombus was more likely to occur in the presence of erythema nodosum and those with high erythrocyte sedimentation rate and platelet count at the time of diagnosis. • Sex has not been shown to have an effect on cardiac involvement.
- 3 March 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (4) , 860-862
Transcatheter closure of a huge complex pulmonary arteriovenous malformation with four devices: a case report
Pulmonary arteriovenous malformations are abnormal vascular connections between pulmonary arteries and veins, often causing right-to-left shunting. In this report, a 4-year-old boy with low oxygen saturation was diagnosed with a large, complex pulmonary arteriovenous malformation involving four feeding arteries. Percutaneous transcatheter closure was performed using four devices to occlude the major feeding arteries, resulting in increased arterial oxygen saturation from 72 to 98%. This report depicts the successful use of multiple devices for percutaneous closure of a complex pulmonary arteriovenous malformation in a child and highlights the minimally invasive and effective nature of this approach.
- 3 March 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (4) , 860-862
Transcatheter closure of a huge complex pulmonary arteriovenous malformation with four devices: a case report
Pulmonary arteriovenous malformations are abnormal vascular connections between pulmonary arteries and veins, often causing right-to-left shunting. In this report, a 4-year-old boy with low oxygen saturation was diagnosed with a large, complex pulmonary arteriovenous malformation involving four feeding arteries. Percutaneous transcatheter closure was performed using four devices to occlude the major feeding arteries, resulting in increased arterial oxygen saturation from 72 to 98%. This report depicts the successful use of multiple devices for percutaneous closure of a complex pulmonary arteriovenous malformation in a child and highlights the minimally invasive and effective nature of this approach.
- 21 January 2025
- Published by Academician Publishing
- p. 133-144
Sporcularda Aort Hastalıkları
Yoğun atletik antrenman, kardiyovasküler sistemin verimliliğini artırmak için önemli fizyolojik adaptasyonlara yol açar. Bu süreçte aorta, egzersiz sırasında maruz kaldığı hemodinamik stres nedeniyle kritik bir rol oynar. Bikuspid aort kapağı (BAV) en yaygın doğuştan kalp anomalilerindendir ve aort kapağının iki yaprakçıklı olması ile karakterizedir. Genellikle asemptomatiktir ve erkeklerde daha sık görülür. BAV’lı sporcular spor yapmaya devam edebilir, ancak düzenli kardiyolojik takip gereklidir.Marfan sendromu (MFS), genetik bir hastalık olup, aort kökü genişlemesi ve anevrizma riskini artırır. MFS’li sporcuların erken teşhisi ve düzenli izlenmesi hayati önem taşır. Ağır ve izometrik egzersizlerden kaçınmaları, düşük yoğunluklu sporlarla ilgilenmeleri önerilir. Aort kökü genişlemesi, hem BAV hem de Marfan sendromlu hastalarda sık görülür ve ani kardiyak ölüm riskini artırabilir. Egzersiz sırasında artan hemodinamik yük diseksiyon riskini yükseltir. Bu makale, BAV, Marfan sendromu ve aort kökü genişlemesinin sporcu sağlığına etkilerini ele alarak düzenli kardiyolojik muayeneler ve erken teşhisin önemine dikkat çeker. Sporcuların kalp sağlığı düzenli izlenmeli ve uygun spor dallarına yönlendirilmelidir.
- 21 January 2025
- Published by Academician Publishing
- p. 133-144
Sporcularda Aort Hastalıkları
Yoğun atletik antrenman, kardiyovasküler sistemin verimliliğini artırmak için önemli fizyolojik adaptasyonlara yol açar. Bu süreçte aorta, egzersiz sırasında maruz kaldığı hemodinamik stres nedeniyle kritik bir rol oynar. Bikuspid aort kapağı (BAV) en yaygın doğuştan kalp anomalilerindendir ve aort kapağının iki yaprakçıklı olması ile karakterizedir. Genellikle asemptomatiktir ve erkeklerde daha sık görülür. BAV’lı sporcular spor yapmaya devam edebilir, ancak düzenli kardiyolojik takip gereklidir.Marfan sendromu (MFS), genetik bir hastalık olup, aort kökü genişlemesi ve anevrizma riskini artırır. MFS’li sporcuların erken teşhisi ve düzenli izlenmesi hayati önem taşır. Ağır ve izometrik egzersizlerden kaçınmaları, düşük yoğunluklu sporlarla ilgilenmeleri önerilir. Aort kökü genişlemesi, hem BAV hem de Marfan sendromlu hastalarda sık görülür ve ani kardiyak ölüm riskini artırabilir. Egzersiz sırasında artan hemodinamik yük diseksiyon riskini yükseltir. Bu makale, BAV, Marfan sendromu ve aort kökü genişlemesinin sporcu sağlığına etkilerini ele alarak düzenli kardiyolojik muayeneler ve erken teşhisin önemine dikkat çeker. Sporcuların kalp sağlığı düzenli izlenmeli ve uygun spor dallarına yönlendirilmelidir.